July 24th 2024
Margins < 1 mm also do not increase the risk of cutaneous squamous cell carcinoma recurrence risk if the galea aponeurotica is not involved.
PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa
View More
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
For some skin cancers, clinicians must consider less expensive options than Mohs surgery
April 1st 2013Although Mohs micrographic surgery represents the gold standard for treatment of many skin cancers, says an expert, healthcare reform dictates that dermatologists also consider less costly options when appropriate.
Staged excision techniques for lentigo maligna address challenges
April 1st 2013The many vagaries of lentigo maligna (LM) or melanoma in situ typically demand staged excision techniques for maximal margin control, according to an expert who spoke at the 71st annual American Academy of Dermatology conference.
Clinical research zeroes in on targeted therapies for skin cancers
March 18th 2013Continued research has led to new and exciting noninvasive therapies for basal cell carcinoma (BCC), lentigo maligna and malignant melanoma, offering some patients an alternative to surgery and/radiation treatment approaches.
Organ transplant recipients present unique challenges for skin cancer care
March 18th 2013The treatment and management of skin cancers in organ transplant recipients (OTR) is challenging. Recent breakthrough medications and combination treatment approaches have resulted in more effective therapeutic options for this patient population.
High-tech imaging modalities identify perineural spread of head and neck malignancies
December 31st 2012High-tech imaging modalities are helpful in detecting metastatic neural spread of tumors, a process known as perineural spread (PNS), and thus can be instrumental in better managing the patient, says Barton Lane, M.D.